Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, Tolerability and Efficacy of THDBH151 in Adult Gout Patients
CTR20240980Phase 2Completed
- Sponsor
- Dongbao Zixing (Hangzhou) Biomedical Co., Ltd.
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of THDBH151 in gout, sponsored by Dongbao Zixing (Hangzhou) Biomedical Co., Ltd.. Started Mar 2024; status: completed.
02
Drugs
THDBH151
03
Conditions
gout
Beyond the preview
Go deeper on CTR20240980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240980.